Overview

Optimizing Patient-centred Outcomes Using Opioid Minimization Strategies: The OPUS Anesthesia Pilot Trial

Status:
RECRUITING
Trial end date:
2027-10-01
Target enrollment:
Participant gender:
Summary
Up to 40% of patients experience suboptimal recovery in the days following major surgery, limiting their return to functional independence. Few preventive interventions exist, but intravenous dexmedetomidine and lidocaine administered during general anesthesia represent simple strategies that may significantly impact recovery and other patient-centred outcomes after surgery. The goal of this pilot trial is to determine the feasibility of conducting a phase 3 pragmatic adaptive multicentre trial to evaluate the impact of dexmedetomidine and lidocaine administered during major non-cardiac surgery on patient-centred outcomes.
Phase:
NA
Details
Lead Sponsor:
CHU de Quebec-Universite Laval
Collaborators:
Canadian Institutes of Health Research (CIHR)
Canadian Perioperative Anesthesia Clinical Trials (PACT) Group
International Anesthesia Research Society (IARS)
Treatments:
Control Groups
Dexmedetomidine
Lidocaine